X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3256) 3256
male (2296) 2296
bortezomib (2105) 2105
pyrazines - administration & dosage (2036) 2036
female (1757) 1757
animals (1487) 1487
pyrazines - pharmacology (1411) 1411
middle aged (1381) 1381
pyrazines - therapeutic use (1364) 1364
boronic acids - administration & dosage (1238) 1238
oncology (1117) 1117
aged (1100) 1100
adult (997) 997
multiple myeloma - drug therapy (981) 981
antineoplastic combined chemotherapy protocols - therapeutic use (805) 805
hematology (796) 796
pyrazines - adverse effects (754) 754
treatment outcome (732) 732
boronic acids - therapeutic use (700) 700
multiple myeloma (664) 664
mice (661) 661
rats (634) 634
pharmacology & pharmacy (579) 579
boronic acids - adverse effects (505) 505
boronic acids - pharmacology (503) 503
sitagliptin phosphate (492) 492
antineoplastic agents - therapeutic use (491) 491
cancer (459) 459
dexamethasone - administration & dosage (443) 443
apoptosis (432) 432
dose-response relationship, drug (430) 430
therapy (411) 411
care and treatment (405) 405
cell line, tumor (370) 370
diabetes mellitus, type 2 - drug therapy (361) 361
antineoplastic agents - administration & dosage (354) 354
research (354) 354
thalidomide - administration & dosage (349) 349
chemotherapy (340) 340
apoptosis - drug effects (339) 339
aged, 80 and over (338) 338
antineoplastic agents - pharmacology (327) 327
drug therapy, combination (318) 318
proteasome inhibitors (306) 306
drug therapy (305) 305
pyrazines - pharmacokinetics (305) 305
multiple-myeloma (301) 301
endocrinology & metabolism (299) 299
antineoplastic combined chemotherapy protocols - adverse effects (294) 294
analysis (291) 291
dexamethasone (291) 291
thalidomide - analogs & derivatives (287) 287
antineoplastic agents - adverse effects (277) 277
rats, sprague-dawley (275) 275
administration, oral (271) 271
drug administration schedule (265) 265
medicine & public health (264) 264
thalidomide (264) 264
multiple myeloma - pathology (259) 259
time factors (258) 258
triazoles - therapeutic use (257) 257
expression (256) 256
dosage and administration (247) 247
sitagliptin (245) 245
hypoglycemic agents - therapeutic use (226) 226
stem-cell transplantation (225) 225
transplantation (220) 220
type 2 diabetes (220) 220
disease models, animal (216) 216
triazoles - administration & dosage (216) 216
survival (215) 215
drug synergism (213) 213
health aspects (212) 212
recurrence (211) 211
activation (207) 207
clinical trials as topic (207) 207
protease inhibitors - therapeutic use (207) 207
abridged index medicus (206) 206
antineoplastic combined chemotherapy protocols - administration & dosage (206) 206
hematology, oncology and palliative medicine (203) 203
trial (202) 202
cells (195) 195
nf-kappa-b (191) 191
multiple myeloma - mortality (190) 190
hypoglycemic agents - administration & dosage (186) 186
combination (185) 185
prognosis (184) 184
diabetes (182) 182
retrospective studies (181) 181
multiple myeloma - therapy (180) 180
proteasome inhibitor bortezomib (177) 177
disease-free survival (173) 173
efficacy (172) 172
melphalan - administration & dosage (171) 171
multiple myeloma - complications (171) 171
cell proliferation - drug effects (170) 170
lenalidomide (170) 170
thalidomide - therapeutic use (169) 169
pharmacokinetics (168) 168
follow-up studies (163) 163
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4032) 4032
Chinese (112) 112
Japanese (80) 80
French (41) 41
German (34) 34
Italian (31) 31
Russian (18) 18
Spanish (15) 15
Czech (10) 10
Hungarian (7) 7
Portuguese (7) 7
Slovak (4) 4
Polish (3) 3
Hebrew (2) 2
Swedish (2) 2
Turkish (2) 2
Danish (1) 1
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9739, pp. 431 - 439
Journal Article
Blood, ISSN 0006-4971, 08/2015, Volume 126, Issue 6, pp. 721 - 732
Waldenstrom macroglobulinemia (WM) is a B-cell neoplasm manifested by the accumulation of clonal immunoglobulin (Ig)M-secreting lymphoplasmacytic cells. MYD88... 
CONSENSUS PANEL RECOMMENDATIONS | 2ND INTERNATIONAL WORKSHOP | L265P SOMATIC MUTATION | MULTIPLE-MYELOMA | RITUXIMAB THERAPY | IMMUNOGLOBULIN-M | MYD88 L265P | LYMPHOPROLIFERATIVE DISORDERS | LYMPHOPLASMACYTIC CELLS | INHIBITOR EVEROLIMUS | HEMATOLOGY | Cyclophosphamide - administration & dosage | Nitrogen Mustard Compounds - administration & dosage | Waldenstrom Macroglobulinemia - therapy | Humans | Middle Aged | Pyrazines - administration & dosage | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Transplantation, Autologous | Molecular Targeted Therapy | Waldenstrom Macroglobulinemia - pathology | Adult | Receptors, CXCR4 - genetics | B-Lymphocytes - pathology | Boronic Acids - administration & dosage | Everolimus | B-Lymphocytes - metabolism | Waldenstrom Macroglobulinemia - diagnosis | Immunoglobulin M - genetics | Gene Expression | Genetic Predisposition to Disease | Sirolimus - analogs & derivatives | Bortezomib | Pyrimidines - administration & dosage | Myeloid Differentiation Factor 88 - genetics | Antineoplastic Combined Chemotherapy Protocols | Hematopoietic Stem Cell Transplantation | Rituximab | Vidarabine - analogs & derivatives | Cladribine - administration & dosage | Plasmapheresis | Receptors, CXCR4 - metabolism | B-Lymphocytes - drug effects | Sirolimus - administration & dosage | Pyrazoles - administration & dosage | Bendamustine Hydrochloride | Aged | Oligopeptides - administration & dosage | Vidarabine - administration & dosage | Myeloid Differentiation Factor 88 - metabolism | Waldenstrom Macroglobulinemia - genetics
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 934 - 941
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2010, Volume 28, Issue 30, pp. 4630 - 4634
Journal Article
Diabetes care, ISSN 1935-5548, 2011, Volume 35, Issue 2, pp. 252 - 258
Journal Article
Diabetes care, ISSN 1935-5548, 2014, Volume 37, Issue 8, pp. 2149 - 2158
Journal Article
British Journal of Haematology, ISSN 1365-2141, 07/2007, Volume 138, Issue 2, pp. 176 - 185
Journal Article
Blood, ISSN 1528-0020, 2012, Volume 120, Issue 1, pp. 9 - 19
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1195 - 1206
Journal Article